BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35935413)

  • 1. Relationship Between MR Spectroscopy-Detected Glutamatergic Neurometabolites and Changes in Social Behaviors in a Pilot Open-Label Trial of Memantine for Adults With Autism Spectrum Disorder.
    Nair N; Hegarty JP; Cirstea CM; Gu M; Appling CB; Beversdorf DQ
    Front Psychiatry; 2022; 13():898006. PubMed ID: 35935413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Dorsolateral Prefrontal Cortex Glutamate/Glutamine Levels Following Repetitive Transcranial Magnetic Stimulation in Young Adults With Autism.
    Moxon-Emre I; Daskalakis ZJ; Blumberger DM; Croarkin PE; Lyon RE; Forde NJ; Tani H; Truong P; Lai MC; Desarkar P; Sailasuta N; Szatmari P; Ameis SH
    Front Neurosci; 2021; 15():711542. PubMed ID: 34690671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [¹H]MRS study.
    Horder J; Lavender T; Mendez MA; O'Gorman R; Daly E; Craig MC; Lythgoe DJ; Barker GJ; Murphy DG
    Transl Psychiatry; 2013 Jul; 3(7):e279. PubMed ID: 23838890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurometabolite levels in the brains of patients with autism spectrum disorders: A meta-analysis of proton magnetic resonance spectroscopy studies (N = 1501).
    Du Y; Chen L; Yan MC; Wang YL; Zhong XL; Xv CX; Li YB; Cheng Y
    Mol Psychiatry; 2023 Jul; 28(7):3092-3103. PubMed ID: 37117459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased glutamate + glutamine levels in the thalamus of patients with essential tremor: A preliminary proton MR spectroscopic study.
    Barbagallo G; Arabia G; Novellino F; Nisticò R; Salsone M; Morelli M; Rocca F; Quattrone A; Caracciolo M; Sabatini U; Cherubini A; Quattrone A
    Parkinsonism Relat Disord; 2018 Feb; 47():57-63. PubMed ID: 29203059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential neurometabolite alterations in brains of medication-free individuals with bipolar disorder and those with unipolar depression: a two-dimensional proton magnetic resonance spectroscopy study.
    Li H; Xu H; Zhang Y; Guan J; Zhang J; Xu C; Shen Z; Xiao B; Liang C; Chen K; Zhang J; Wu R
    Bipolar Disord; 2016 Nov; 18(7):583-590. PubMed ID: 27870506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance spectroscopy features of the thalamus and the cerebellum and their association with clinical features in children with autism spectrum disorder: a prospective study.
    Kang QQ; Li X; Tong GL; Fan YL; Shi L
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Dec; 23(12):1250-1255. PubMed ID: 34911608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton magnetic resonance spectroscopy as a probe into the pathophysiology of autism spectrum disorders (ASD): a review.
    Baruth JM; Wall CA; Patterson MC; Port JD
    Autism Res; 2013 Apr; 6(2):119-33. PubMed ID: 23436782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased glutamate + glutamine in Alzheimer's disease detected in vivo with (1)H-MRS at 0.5 T.
    Antuono PG; Jones JL; Wang Y; Li SJ
    Neurology; 2001 Mar; 56(6):737-42. PubMed ID: 11274307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemistry of the cingulate cortex in autism: An MR spectroscopy study.
    Libero LE; Reid MA; White DM; Salibi N; Lahti AC; Kana RK
    Autism Res; 2016 Jun; 9(6):643-57. PubMed ID: 26526126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decoupling of N-acetyl-aspartate and glutamate within the dorsolateral prefrontal cortex in schizophrenia.
    Coughlin JM; Tanaka T; Marsman A; Wang H; Bonekamp S; Kim PK; Higgs C; Varvaris M; Edden RA; Pomper M; Schretlen D; Barker PB; Sawa A
    Curr Mol Med; 2015; 15(2):176-83. PubMed ID: 25732147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of insulin infusion on the metabolites in cerebral tissues assessed with proton magnetic resonance spectroscopy in young healthy subjects with high and low insulin sensitivity.
    Karczewska-Kupczewska M; Tarasów E; Nikolajuk A; Stefanowicz M; Matulewicz N; Otziomek E; Górska M; Straczkowski M; Kowalska I
    Diabetes Care; 2013 Sep; 36(9):2787-93. PubMed ID: 23596182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor cortex metabolite alterations in amyotrophic lateral sclerosis assessed in vivo using edited and non-edited magnetic resonance spectroscopy.
    Weerasekera A; Peeters R; Sima D; Dresselaers T; Sunaert S; De Vocht J; Claeys K; Van Huffel S; Van Damme P; Himmelreich U
    Brain Res; 2019 Sep; 1718():22-31. PubMed ID: 31002818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased glutamate concentration in the auditory cortex of persons with autism and first-degree relatives: a (1)H-MRS study.
    Brown MS; Singel D; Hepburn S; Rojas DC
    Autism Res; 2013 Feb; 6(1):1-10. PubMed ID: 23166003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A proton MR spectroscopy study of the thalamus in twins with autism spectrum disorder.
    Hegarty JP; Gu M; Spielman DM; Cleveland SC; Hallmayer JF; Lazzeroni LC; Raman MM; Frazier TW; Phillips JM; Reiss AL; Hardan AY
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():153-160. PubMed ID: 28941767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supplementation of Antipsychotic Treatment with the Amino Acid Sarcosine Influences Proton Magnetic Resonance Spectroscopy Parameters in Left Frontal White Matter in Patients with Schizophrenia.
    Strzelecki D; Podgórski M; Kałużyńska O; Gawlik-Kotelnicka O; Stefańczyk L; Kotlicka-Antczak M; Gmitrowicz A; Grzelak P
    Nutrients; 2015 Oct; 7(10):8767-82. PubMed ID: 26506383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetaldehyde-mediated increase in glutamatergic and N-acetylaspartate neurometabolite levels in the midcingulate cortex of ALDH2*1/*2 heterozygous young adults.
    Ueno F; Sakuma M; Nakajima S; Tsugawa S; Ochi R; Tani H; Noda Y; Graff-Guerrero A; Uchida H; Mimura M; Oshima S; Matsushita S
    Alcohol Clin Exp Res (Hoboken); 2024 Jan; 48(1):58-71. PubMed ID: 38206287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adding Sarcosine to Antipsychotic Treatment in Patients with Stable Schizophrenia Changes the Concentrations of Neuronal and Glial Metabolites in the Left Dorsolateral Prefrontal Cortex.
    Strzelecki D; Podgórski M; Kałużyńska O; Stefańczyk L; Kotlicka-Antczak M; Gmitrowicz A; Grzelak P
    Int J Mol Sci; 2015 Oct; 16(10):24475-89. PubMed ID: 26501260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability study.
    Plitman E; Chavez S; Nakajima S; Iwata Y; Chung JK; Caravaggio F; Kim J; Alshehri Y; Chakravarty MM; De Luca V; Remington G; Gerretsen P; Graff-Guerrero A
    Psychiatry Res Neuroimaging; 2018 Mar; 273():16-24. PubMed ID: 29414127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased prefrontal GABA concentrations in adults with autism spectrum disorders.
    Maier S; Düppers AL; Runge K; Dacko M; Lange T; Fangmeier T; Riedel A; Ebert D; Endres D; Domschke K; Perlov E; Nickel K; Tebartz van Elst L
    Autism Res; 2022 Jul; 15(7):1222-1236. PubMed ID: 35587691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.